About This Medication # Novartis Patient Assistance Foundation (NPAF) Patient Guide: How to Get **Tasigna (nilotinib)** at Low or No Cost Tasigna (nilotinib) is a targeted therapy medication used to treat **chronic myeloid leukemia (CML)** in adults and children. Get your Tasigna (Nilotinib) for only $70.00 per month through our patient assistance program. Enroll today and get pre-qualified. Novartis Patient Support is a program designed to help your eligible patients start, stay, and save on TASIGNA. To learn more, call 1-800-282-7630. FAQs Get answers to common questions about Tasigna (nilotinib) copay assistance, patient savings programs, and how QuickRx can help you afford your medication. Novartis United States Navigate Novartis Patients & caregivers Healthcare professionals ESG News Careers Media center How much will you actually pay for Tasigna? In 30 seconds, see every legitimate way to afford Tasigna — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash. Transfer your prescription for TASIGNA 50 MG CAP on Amazon Pharmacy. FREE SHIPPING for Prime members. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people's lives so that patients, health care professionals, and societies are empowered in the face of serious disease. Novartis Patient Assistance Foundation, Inc. (NPAF) is an independent, non-profit organization which provides Novartis medications free of cost to eligible patients. Compare Tasigna 150 mg prices from verified online pharmacies or local U.S. pharmacies. Free coupons for tasigna. Discounts up to 80% off the retail price. Tasigna can interact with many medicines and supplements and increase your chance for serious and life-threatening side effects. See "What is the most important information I should know about Tasigna?" Specialty drug How to get this medication Generic Tasigna is a specialty medication, which can cost more than standard prescriptions and involve a few extra steps. We'll help you understand what to expect. Compare Tasigna prices, print discount coupons, find manufacturer promotions, copay cards and patient assistance programs. Weston, Florida (May 23, 2025) – Apotex Corp. today announced the launch of nilotinib capsules, a generic version of Tasigna® 1, in the United States, with 180 days of exclusivity. Nilotinib is a kinase inhibitor indicated to treat certain types of leukemia, including newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia ("Ph+ CML") in chronic phase in adults and … Tasigna is a kinase inhibitor indicated for the treatment of: Adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. (1.1) Adult patients with chronic phase (CP) and accelerated phase (AP) Ph+ CML resistant to or intolerant to prior therapy that included imatinib. (1.2 … WESTON, Fla., May 27, 2025 /PRNewswire/ – Apotex Corp. today announced the launch of nilotinib capsules, a generic version of Tasigna®, in the United States, with 180 days of exclusivity … Apotex Corp View company profile. announced the launch of nilotinib View drug details capsules, the first generic version of Tasigna View drug details ® in the United States, with 180 days of market exclusivity. The kinase (search) Search target inhibitor is indicated for treating Philadelphia chromosome positive chronic myeloid leukemia (search) Search disease in adults and children aged 1 … What you need to know about generic Tasigna: effectiveness comparison, potential differences, and cost savings for CML patients. Nilotinib, sold under the brand name Tasigna or Cavhanza among others, is an anti-cancer medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. [2][6] It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib. [2][6][7] It is taken by mouth. [2][7] Common side effects … Get Medicare savings updates for Tasigna Receive price alerts, news, and other messages from GoodRx about Tasigna and other healthcare topics and relevant savings offers. Tasigna (nilotinib) is a brand-name drug that's used to treat certain forms of CML in adults and children. Learn about side effects, dosage, uses, and more. Learn about Tasigna (nilotinib) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. A generic version of nilotinib (Tasigna®) entered the US market on May 27, 2025, with 180 days of exclusivity, reported Apotex, the pharmaceutical company that introduced the therapy to the US market. Nilotinib treats Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in adults and children ages 1 and older, including newly diagnosed chronic phase and relapsed or refractory … 1. Background: Step Therapy programs are utilized to encourage the use of lower cost alternatives for certain therapeutic classes. This program requires a patient trial or physician consideration of imatinib before providing coverage for Tasigna in the setting of Philadelphia chromosome-positive chronic myelogenous/myeloid leukemia. Tasigna is an oral chemotherapy drug manufactured by Novartis that treats Philadelphia chromosome-positive chronic myeloid leukemia in children and adults. Get the best price on Tasigna at pharmacies near you with SingleCare. Save up to 80% with our Tasigna coupons – with or without insurance! Find patient medical information for Nilotinib (Danziten, Tasigna) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Novartis' Patient Assistance Foundation (PAF) can help patients acquire high-cost drugs for free or at reduced prices. For assistance acquiring nilotinib, visit the online enrollment page, select nilotinib, and fill in the required information. Novartis will make Tasigna available throughout the US within days following this approval by the Food and Drug Administration (FDA) to meet the treatment needs of these patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). TASIGNA® (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking Tasigna® and each time you get a refill. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment. Apotex has launched the first generic version of Tasigna (nilotinib), a TKI used to treat adult and pediatric patients with Ph+ CML. Wondering when a generic version of Tasigna will be available? Get details on FDA approval status, generic manufacturers, and patent expirations. Please contact us if we can be of service to you. Here are some links to the most common plans for CML: Patient Assistance NOW (PANO) Gleevec**/Tasigna (Imatinib/Nilotinib) – Novartis Oncology Tasigna Co-Pay Assistance Discount Card program for commercially insured patients. Patient Assistance NOW (PANO) for UNINSURED patients. Save up to 80% on your Tasigna prescription at pharmacies nationwide. Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia. Includes Tasigna side effects, interactions and indications. Tasigna is also referred to by its drug name, nilotinib. Tasigna is used as targeted therapy for leukemia. Tasigna is a member of a class of drugs called tyrosine kinase inhibitors. Tasigna is believed to work by inhibiting cellular replication and triggering cell death in leukemia cells. How do I take it? Apotex has launched the first generic version of Tasigna (nilotinib), a treatment for Ph+ chronic myeloid leukemia. If you have insurance and are looking for patient assistance or copay assistance for Nilotinib (Tasigna®), we have provided links that may help. Visit our Patient Assistance page and click the links to various patient assistance programs for help paying for Nilotinib (Tasigna®). Tasigna (nilotinib) remains a high-value oncology asset in chronic myeloid leukemia (CML) and is priced and defended through a mature, multi-layer patent estate, coupled with ongoing US FDA oversight and generic entry gating via Orange Book-listed patents and litigation. For people with Ph+ CML and caregivers, Tasigna Generic: Alternatives explains generic nilotinib access, treatment choices, safety checks, and monitoring.